含紫杉醇方案治疗晚期胃癌的临床观察

  目的 评价两种含紫杉醇（TAX）方案治疗晚期胃癌的临床疗效及安全性。方法 31例病理证实的晚期胃癌患者接受两种含紫杉醇方案化疗，即：紫杉醇+５-氟尿嘧啶（TF方案）19例；紫杉醇+顺铂（TP方案）12例。使用过5-氟尿嘧啶类药物的患者入TP组，其余入TF组，21 d为1周期，连用2周期后评价疗效。结果 31例患者均可评价疗效与不良反应，TF方案有效率为47.4 ％，TP方案有效率为41.7 ％，总有效率为45.2 ％，临床受益率（CBR）为80.6 ％。副作用主要是白细胞减少，发生率58.1 ％，Ⅲ度以上占9.7 ％；胃肠道反应发生率为38.7 ％。结论 含紫杉醇方案有确切疗效，CBR高，不良反应可耐受，对多次使用含5-氟尿嘧啶及衍生物方案化疗过的患者，选用TP方案仍有效。

Clinical study on Taxol-based combination chemotherapy for patients with advanced gastric cancer

Objective To evaluate the efficacy and toxicity of Taxol-based chemotherapy in patients with advanced gastric cancer. Methods Thirty-one patients with advanced gastric cancer were treated with two kinds of Taxol-based chemotherapy schedule. The treatment schedule were composed of paclitaxel and fluorouracil(TF) or cisplatin(TP). The patients who had had chemotherapy with fluorouracil were arranged to TP group,others to TF group. A treatment cycle lasted 21 days. The efficacy was evaluated after two cycles of the chemotherapy. Results total efficiency rate of two groups was 45.2 %; the efficiency rate of TF was 47.4 %; the rate of TP was 41.7 %; CBR was 80.6 %. The main side effect of toxicity were neutropenia and nausea as well as vomiting. Conclusion Taxol-based combination chemotherapy is a high response protocol with mild toxicity. TP schedule has a high efficiency for advanced gastric cancer.